You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
|
---|---|
Published in |
Trials, January 2019
|
DOI | 10.1186/s13063-018-3158-6 |
Pubmed ID | |
Authors |
Farsad Eskandary, Michael Dürr, Klemens Budde, Konstantin Doberer, Roman Reindl-Schwaighofer, Johannes Waiser, Markus Wahrmann, Heinz Regele, Andreas Spittler, Nils Lachmann, Christa Firbas, Jakob Mühlbacher, Gregor Bond, Philipp F. Halloran, Edward Chong, Bernd Jilma, Georg A. Böhmig |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 2 | 14% |
Venezuela, Bolivarian Republic of | 1 | 7% |
Spain | 1 | 7% |
Italy | 1 | 7% |
United States | 1 | 7% |
Germany | 1 | 7% |
Unknown | 7 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 71% |
Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Scientists | 2 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 77 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 12% |
Student > Bachelor | 9 | 12% |
Researcher | 7 | 9% |
Student > Doctoral Student | 7 | 9% |
Student > Master | 6 | 8% |
Other | 10 | 13% |
Unknown | 29 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 29% |
Biochemistry, Genetics and Molecular Biology | 8 | 10% |
Immunology and Microbiology | 5 | 6% |
Nursing and Health Professions | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 6 | 8% |
Unknown | 28 | 36% |